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Abstract
Background: Approximately 5% of patients with an acute coronary syndrome are discharged
from the emergency room with an erroneous diagnosis of non-cardiac chest pain. Highly accurate
non-invasive stress imaging is valuable for assessment of low-risk chest pain patients to prevent
these errors. Adenosine stress cardiovascular magnetic resonance (AS-CMR) is an imaging
modality with increasing application. The goal of this study was to evaluate the negative prognostic
value of AS-CMR among low-risk acute chest pain patients.
Methods: We studied 103 patients, mean 56.7 ± 12.3 years of age, with chest pain and no
electrocardiographic evidence of ischemia and negative cardiac biomarkers of necrosis, who were
admitted to the Cardiac Decision Unit of our institution. All patients underwent AS-CMR. A
negative AS-CMR was defined as absence of all the following: regional wall motion abnormalities at
rest; perfusion defects during stress (adenosine) and rest; and myocardial scar on late gadolinium
enhancement images. The patients were followed for a mean of 277 (range 161-462) days. The
primary end point was defined as the combination of cardiac death, nonfatal acute myocardial
infarction, re-hospitalization for chest pain, obstructive coronary artery disease (>50% coronary
stenosis on invasive angiography) and coronary revascularization.
Results: In 14 patients (13.6%), AS-CMR was positive. The remaining 89 patients (86.4%), who had
negative AS-CMR, were discharged. No patient with negative AS-CMR reached the primary end-
point during follow-up. The negative predictive value of AS-CMR was 100%.
Conclusion: AS-CMR holds promise as a useful tool to rule out significant coronary artery disease
in patients with low-risk chest pain. Patients with negative AS-CMR have an excellent short and
mid-term prognosis.
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Background
Acute chest pain is one of the most common reasons for
presentation to the emergency department [1]. The main
tools for the initial triage of patients include history, elec-
trocardiogram, and cardiac biomarkers of necrosis, which
identify a large number of patients who would require
admission and further management. The real challenge in
contemporary chest pain units is the identification of
patients with low-risk chest pain who could safely be dis-
charged because on one hand, the "inappropriate" admis-
sion of these patients would pose a great burden of cost,
while on the other, missing a diagnosis of chest pain of
cardiac origin is associated with increased risk for adverse
cardiac events in follow-up [2]. Furthermore, such a
missed diagnosis is a frequent reason for malpractice
claims [3]. Several advances in patients' triage, including
new non-invasive imaging techniques [4] such as dob-
utamine stress echocardiography, stress nuclear studies,
computed tomography coronary angiography and,
recently, stress cardiovascular magnetic resonance (CMR),
have enhanced the accuracy and efficiency of evaluation
of patients with acute chest pain [5]. Highly desirable fea-
tures of such techniques include a high negative prognos-
tic value, i.e. a negative study would allow the safe
discharge of patients with low-risk chest pain. The effi-
cacy, however, of stress CMR in this setting has yet to be
adequately explored. The aim of the present study was to
assess the negative prognostic value of adenosine stress
CMR (AS-CMR) in patients presenting to the emergency
department with low-risk acute chest pain.
Methods
Study population
From July 2007 through May 2008, we enrolled 103
patients who presented to the emergency department with
low-risk acute chest pain. This was a single center, retro-
spective study. All patients were examined clinically and
cardiovascular risk factors were assessed, including
tobacco use, diabetes mellitus, hypertension, hypercho-
lesterolemia, family history of coronary artery disease
(CAD) and history of previous CAD. Previous CAD was
defined as previous myocardial infarction, CAD on car-
diac catheterization, previous percutaneous coronary
intervention or previous coronary artery bypass grafting.
All cardiovascular medications were recorded. Low-risk
acute chest pain was specified as no persistent ischemic-
type chest pain with no objective evidence of myocardial
ischemia, based on the negative results of serial serum car-
diac biomarkers of necrosis (troponin I, MB fraction of
creatinine kinase) as well as normal or inconclusive elec-
trocardiograms (not indicative of ST-segment elevation
myocardial infarction and without ≥2 mm T-wave inver-
sion or >0.5 mm ST-segment depression). The exclusion
criteria were standard contraindications for magnetic res-
onance imaging, such as internal pacemaker or defibrilla-
tor, cerebral aneurysm clips or metal in the eye;
contraindications for adenosine administration, such as
bronchospasm, high degree atrioventricular block, known
allergic reaction to the medicine; pulmonary embolism;
acute neurological disease; high clinical suspicion of acute
aortic syndrome; and New York Heart Association class IV
congestive heart failure symptoms.
All patients underwent AS-CMR within 24 hours of their
presentation to the emergency department. This study had
institutional review board approval from Emory Univer-
sity.
AS-CMR protocol
The AS-CMR protocol was carried out on a 1.5T Siemens
Avanto system (Erlangen, Germany). The patient was
positioned feet-first supine, with a 6-channel flexible
body phased array coil anteriorly and a 24-element spine
array for posterior signal reception. Three-lead ECG was
applied to the chest with waveform monitoring through-
out the study. The entire imaging protocol was completed
in approximately 45 minutes (Figure 1).
Initial localization of the cardiac chambers was achieved
using a T2-weighted single-shot fast spin echo (HASTE)
sequence. Subsequently, breath-hold steady-state free pre-
cession (SSFP) cine acquisitions were acquired in the ver-
tical long-axis, horizontal long-axis, basal short-axis, true
four-chamber, and left ventricular outflow track orienta-
tions. Each orientation was prescribed using the preceding
acquisition. First-pass perfusion (both at stress and rest)
was performed with a saturation-prepared turbo flash
acquisition. Three slices were oriented in the short-axis
plane (base, mid, apex), prescribed from the cine four-
chamber view. A test scan was performed with 5 dynamic
images to confirm absence of artifacts and proper visuali-
zation of the LV myocardium and blood pool. The
sequence was copied and 60 dynamics were implemented
for perfusion imaging. Adenosine was administered intra-
venously at 140 μg/kg/min. Four minutes into the infu-
sion, the stress perfusion imaging was performed, with
0.05 mmol/kg gadobenate dimeglumine (MultiHance),
Bracco Diagnostics Inc., Princeton, NJ. The perfusion
pulse sequence was initiated 3 seconds prior to gadolin-
ium infusion, followed by a breath-hold command, and
lasted for approximately 1 min. Adenosine infusion was
stopped after the acquisition. After a brief period, during
which optional images, such as flow sequences, were
obtained, rest perfusion was performed with a second
dose of 0.05 mmol/kg MultiHance, using the same acqui-
sition method as was used for stress perfusion imaging.
An additional 0.1 mmol/kg of MultiHance contrast was
administered following rest perfusion for late gadolinium
enhancement (LGE) imaging. Multi-slice SSFP cine short-
axis imaging was subsequently performed. AcquisitionJournal of Cardiovascular Magnetic Resonance 2009, 11:37 http://www.jcmr-online.com/content/11/1/37
Page 3 of 7
(page number not for citation purposes)
extended from the atrial side of the ventricular valve plane
to just beyond the apex. Approximately seven minutes
after the final contrast dose, a multi-phase inversion-
recovery SSFP scan was acquired in the mid short-axis
plane, in order to determine the optimal inversion time
(TI) to null normal myocardium for LGE imaging. The
time that corresponded to the image with sufficiently
nulled myocardium was entered as the TI into the subse-
quent inversion recovery segmented turbo flash sequence
used for LGE imaging. Acquisition was performed in the
short-axis, and covered the same anatomic range as the
SSFP cine short-axis stack. In addition, single slices were
acquired in the vertical long-axis, four chamber and left
ventricular outflow tract views to correspond to the cine
acquisitions. The TI was increased as needed as time
passed.
Left ventricular ejection fraction was calculated off-line
from end-diastolic and end-systolic endocardial tracings
of the multi-slice SSFP cine short-axis images using com-
puter-assisted planimetry. A negative AS-CMR was
defined as the absence of all of the following: resting wall
motion abnormalities on cine images, perfusion defects
during adenosine infusion, or LGE in a coronary disease-
type pattern (subendocardial enhancement). A positive
AS-CMR had one or more of these features. A myocardial
perfusion defect was reported if a segment was definitely
darker than surrounding myocardium and persisted more
The AS-CMR protocol Figure 1
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than three images beyond initial peak enhancement of the
segment which appeared most normal. LGE images were
displayed with a gray scale to optimally show normal
myocardium as dark and the regions of LGE or fat as
bright. The AS-CMRs were interpreted qualitatively by
consensus of two Level III CMR trained cardiologists or
radiologists.
Follow-up
The follow-up was completed in October 2008. The pri-
mary end point was defined as the combination of cardiac
death, nonfatal myocardial infarction, re-hospitalization
for unstable angina, obstructive CAD (defined as at least
one coronary lesion of >50% stenosis on invasive coro-
nary angiography) and coronary revascularization. Cardi-
ovascular events during follow-up were identified for
these patients by reviewing their medical data from our
comprehensive institutional electronic records for clinic
visits, new emergency department visits or hospital
admissions. Myocardial infarction was defined based on
the 2007 ESC/ACCF/AHA/WHF expert consensus docu-
ment for the universal definition of myocardial infarction
[6]. Cardiac death was defined as death associated with
known or suspected acute myocardial infarction, life
threatening arrhythmia, or cardiogenic pulmonary
edema. Re-hospitalization for chest pain was defined as a
recurrent episode of chest pain requiring hospital admis-
sion.
Statistical analysis
Continuous variables are presented as mean ± SD or
median (range). Qualitative variables are presented as
absolute and relative frequencies. All analysis used a two
tailed p value with a significance level of < 0.05. Statistical
analyses were performed using the SAS statistical package
version 9 (SAS Institute, North Carolina, USA).
Results
During the 13 months of enrollment, 103 patients, 56.7 ±
12.3 years of age, with low-risk chest pain were included
as study patients. Patients' characteristics, demographic
data and medications at baseline are listed in Table 1. AS-
CMR was performed in all cases without adverse events.
The median duration of follow-up was 277 days (range
161 to 462 days). All 103 cases were followed up. There
was no myocardial infarction, cardiovascular death or
death from other cause in the study population.
A total of 14 patients (13.6% of the study population) had
abnormal findings on AS-CMR. Six of these 14 patients
(5.8%) had resting regional wall motion abnormalities,
ten patients (9.7%) had perfusion defects during stress,
and five patients (4.9%) had evidence of scar on LGE
images. Six of the patients with an abnormal AS-CMR had
a previously known history of CAD. Four patients refused
further evaluation. From the remaining ten, five were
advised to undergo coronary angiography, and all of these
had obstructive CAD (one received percutaneous coro-
nary intervention). Another four of the ten had known
coronary anatomy from recent coronary angiography, and
one with only a small area of ischemia was managed con-
servatively without undergoing coronary angiography. All
patients received standard pharmacological treatment for
secondary prevention of CAD. During the follow-up
period, the conservatively-managed patient with a small
area of ischemia presented again with chest pain and was
admitted; coronary angiography was performed revealing
luminal irregularities with no need for interventional
treatment. Another two patients with known CAD and
scar in the original AS-CMR were readmitted because of
chest pain and underwent coronary angiography, with no
need for revascularization. There were no readmissions
for the patients who refused coronary angiography.
The remaining 89 patients (86.4% of the study popula-
tion) had negative AS-CMRs. Seven of them had a known
Table 1: Baseline characteristics of the study population (n = 
103).
Age, years 56.7 ± 12.3
Male gender 38 (36.9%)
Risk factors
Hypertension 66 (64.1%)
Hypercholesterolemia 40 (38.8%)
Diabetes mellitus 30 (29.1%)
Smoking 20 (19.4%)
Family history of CVD 53 (51.5%)
Previous CAD 13 (12.6%)
Medications
Acetylsalicylic acid 30 (29.1%)
ACEi/ARBs 35 (34.0%)
beta-blockers 31 (30.1%)
Calcium channel blockers 19 (18.4%)
Categorical variables are presented as absolute numbers and relative 
frequencies; continuous variables are presented as mean ± SD.
ACEi: angiotensin converting enzyme inhibitors; ARBs: angiotensin 
receptor blockers; CAD: coronary artery disease; CVD: 
cardiovascular disease.Journal of Cardiovascular Magnetic Resonance 2009, 11:37 http://www.jcmr-online.com/content/11/1/37
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history of CAD. All patients were discharged from the
emergency department with risk modification counseling
and/or pharmacological treatment. During the period of
follow-up a total of 9 patients presented again to the
emergency department, all of them with atypical chest
pain. Evaluation of chest pain with serial electrocardio-
grams, serial cardiac biomarkers of necrosis and non-inva-
sive imaging studies did not reveal any case of acute
coronary syndrome and all patients were discharged from
the emergency department, without being admitted. The
negative predictive value of AS-CMR was 100%.
Discussion
The present study has shown that a negative AS-CMR per-
formed within 24 hours of patients presenting to the
emergency department with low-risk chest pain, as indi-
cated by negative serial electrocardiograms and cardiac
biomarkers of necrosis, is associated with an excellent
prognosis.
Approximately 5% of patients with an acute coronary syn-
drome are discharged from the emergency room with an
erroneous diagnosis of non-cardiac chest pain [7]. These
patients are at substantial risk for subsequent cardiac
events, as up to 15% will have a myocardial infarction in
the subsequent two months [2]. Therefore, non-invasive
tests which reliably exclude significant CAD in the acute
setting are of great value, as they have the potential to
reduce inappropriate admissions without increasing the
risk of missed diagnoses.
Prior Stress CMR Protocols
The present study extends the findings of previous studies
examining the predictive value of stress perfusion CMR [8-
15]. Jahnke et al. evaluated a combined sequential adeno-
sine/dobutamine stress CMR imaging protocol, and
showed that in a moderate risk population referred for
ischemic evaluation a perfusion defect on AS-CMR was
the best univariate predictor of death and non-fatal myo-
cardial infarction [13]. In addition, a normal stress CMR
predicted a low annual cardiac event rate in the range of
1%. However, their stress protocol was not solely
employed in the acute setting and presenting symptoms
included dyspnea as well as chest pain.
Also in the non-acute clinical setting, Pilz et al. [14] have
shown that a normal AS-CMR predicts an excellent 1-year
outcome. However, their study population also had var-
ied indications for stress testing, with only 49% of
patients presenting with angina; limiting its applicability
to low risk patients presenting with acute chest pain. In
addition, only patients without perfusion defects or LGE
were included, leaving outcomes to be compared to calcu-
lated event probabilities rather than observed outcomes
of a group with positive AS-CMR.
The high negative predictive value of AS-CMR found in
the present study in patients presenting to the emergency
department with low-risk chest pain concurs with find-
ings from a prior study by Ingkanisorn et al [15], in which
no patient with a normal AS-CMR had a subsequent diag-
nosis of CAD or an adverse outcome over a period of 467
days. While inclusion criteria were similar, all patients in
the current study underwent AS-CMR from our Cardiac
Decision Unit within 24 hours, whereas patients in Ing-
kanisorn et al. waited up to 72 hours with some patients
presumably admitted to the hospital. Our study better val-
idates the utilization of AS-CMR as an initial risk-stratify-
ing diagnostic modality in the acute setting, selecting
those patients who can be safely discharged. Also, only
three short-axis slices were used for first-pass perfusion in
the present study, compared with the "typically at least
nine" slices obtained in Ingkanisorn et al. Therefore, our
protocol maintains the same diagnostic accuracy with a
less labor intensive image acquisition protocol.
Comparison with Other Stress Modalities
Choosing the appropriate non-invasive evaluation for
acute chest pain involves considering test characteristics,
as well as the risks inherent to the test itself. High sensitiv-
ity and negative predictive value, as demonstrated for AS-
CMR in the present study, are essential. For example,
while several studies have shown that patients presenting
to the emergency department with low-risk chest pain can
safely undergo exercise testing within 6 to 12 hours, sen-
sitivity of exercise treadmill alone for detection of CAD
may be as low as 29% [16]. Adding nuclear myocardial
perfusion imaging (MPI) to exercise protocols or pharma-
cologic stress improves sensitivity for detecting significant
CAD, but results in significant exposure to ionizing radia-
tion. Similarly, coronary computed tomography angiogra-
phy (CTA) has a defined role in excluding CAD as the
etiology of acute chest pain [17-20] but also involves radi-
ation exposure and the administration of potentially
nephrotoxic contrast agents. While efforts to decrease the
effective radiation dose of these studies are making head-
way, the attributable risk of fatal malignancy from a single
nuclear MPI study or coronary CTA has been estimated at
1 in 2000 [21].
Stress echocardiography is an attractive alternative for the
evaluation of acute chest pain as it avoids exposure to
radiation or nephrotoxic contrast agents, and includes an
evaluation of cardiac structure and function similar to AS-
CMR. However, the sensitivity of dobutamine stress
echocardiography (DSE) with regional wall motion anala-
ysis (WMA) for detection of significant CAD has been
questioned, and its risks of induced arrhythmia and acute
infarction are appreciable. Tsutsui et al. [22] suggest con-
trast administration with myocardial perfusion analysis
(MPA) is necessary to achieve sufficient sensitivity to reli-Journal of Cardiovascular Magnetic Resonance 2009, 11:37 http://www.jcmr-online.com/content/11/1/37
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ably exclude CAD. However, MPA is a technique not
widely utilized. Contrary to these findings, Bedetti et al.
[23] demonstrated the ability of normal WMA on phar-
macologic stress echocardiogram to exclude significant
CAD in a low risk population presenting with acute chest
pain; as their subsequent coronary event rate was only
1.2% over a median follow-up of 13 months. A definitive
comparison of stress echocardiography to alternative
modalities has yet to be performed. Even if proven effec-
tive, it is estimated that 8% of DSEs done without contrast
are not of diagnostic quality due to poor acoustic win-
dows [24].
In addition to its high diagnostic accuracy and negative
predictive value, AS-CMR is a safe and well tolerated pro-
cedure with only minimal risk to the patient. Due to the
extremely short half-life of adenosine any adverse reac-
tions caused by its infusion are rapidly ended with discon-
tinuation of the drug. In the present study, there were no
adverse effects associated with AS-CMR. Gadobenate
dimeglumine carries a very low risk of nephrotoxicity,
except in patients with end stage renal disease [25]. The
imaging protocol itself was facile for a variety of technol-
ogists to apply with uniformly excellent image quality,
and all studies were completed within the prescribed 45
minutes of cumulative scan time.
AS-CMR has specific advantages over other imaging
modalities in addition to the avoidance of radiation, iodi-
nated contrast, and dobutamine with its known risks.
Unlike other imaging modalities, body habitus does not
affect AS-CMR image quality nor the propensity for false
positive results. In addition, alternative etiologies of chest
pain including aortic dissection, pericarditis, and myocar-
ditis may be accurately identified on AS-CMR. Further-
more, gold standard quantification of ejection fraction as
well as assessment of valvular function are inherent to the
exam. Finally, AS-CMR images can be read immediately
and clinical decisions made quickly, as there is no post-
processing required. This may reduce average length of
stay in chest pain units, increase diagnostic efficiency, and
allow practitioners to care for more patients.
Subpopulations
The results of our study may have specific implications for
women. Although usually underrepresented in studies of
acute coronary syndromes, females were the majority of
our population (63%). This may have partly accounted
for the low incidence of adverse events in our study pop-
ulation and for the excellent negative predictive value of
AS-CMR. Other forms of stress testing encounter specific
obstacles among women, including low specificity for
exercise testing and lower diagnostic accuracy for nuclear
perfusion imaging due to the presence of breast artifact
[26]. Furthermore, there is a greater risk of cancer develop-
ment after radiation exposure (i.e. with computed tomog-
raphy coronary angiography or stress nuclear imaging),
especially among young women [27]. AS-CMR lacks all of
these drawbacks.
The excellent negative predictive value of AS-CMR in our
study population applied to patients both with and with-
out a known history of CAD, although few patients had
known CAD (7 out of 89 patients, 7.8%). According to
current recommendations, patients with known CAD and
low-risk chest pain can be observed in a chest pain unit
and discharged if they have a negative stress test [17]. AS-
CMR may help to distinguish CAD patients at high risk for
future cardiac events from those with low risk and to
guide proper management of these patients.
Limitations
Our study has several limitations. First, this was a single-
center study with small sample size resulting in the
absence of a large number of hard cardiac events such as
myocardial infarction or cardiac death. Secondly, we did
not compare AS-CMR with other non-invasive or invasive
imaging modalities. Third, follow-up was by review of
medical records rather than directly contacting the
patients. Furthermore, we calculated the negative but not
the positive predictive value of AS-CMR. We believe that
the intensive preventive management strategies in our
positive AS-CMR patients could have accounted for a
reduction in their risk; thus, the positive predictive value
of AS-CMR would have been underestimated. Further-
more, a high negative predictive value is the most valuable
characteristic for stress imaging in this clinical setting.
Conclusion
Our study suggests that AS-CMR has high negative predic-
tive value and can be used as a non-invasive stress imaging
modality to safely discharge low-risk chest pain patients
from the emergency department. Additional multicenter,
large-scale studies could provide further insights into this
area.
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